Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 15 employees
- YC batch
- Winter 2020
- Status
- Active
- Stage
- Early stage
